SCHEMBL783967

SCHEMBL783967

O=C(O)CN(CO)CC(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.65
EYA2 O00167 1/20 0.65
APP P05067 1/20 0.65
ACE P12821 1/20 0.65
TSHR P16473 4/20 0.61
LMNA P02545 3/20 0.61
BLM P54132 2/20 0.61
PMP22 Q01453 2/20 0.61
ALOX15 P16050 2/20 0.61
CYP2C19 P33261 2/20 0.61
DRD3 P35462 2/20 0.61
KDM4E B2RXH2 1/20 0.61
CHRM2 P08172 1/20 0.61
ADRA2A P08913 1/20 0.61
DRD1 P21728 1/20 0.61
SLC6A2 P23975 1/20 0.61
SLC6A4 P31645 1/20 0.61
ADRA1A P35348 1/20 0.61
SLC6A3 Q01959 1/20 0.61
HRH3 Q9Y5N1 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1418294 0.97 TDP1 (0.61) TDP1EYA2APPACETSHR
SCHEMBL66358 0.93
Nitrilotriacetic Acid SCHEMBL20409 0.93 TDP1 (0.73) TDP1EYA2APPACETSHR
Nitrilotriacetic Acid SCHEMBL670055 0.93 TDP1 (0.73) TDP1EYA2APPACETSHR
Nitrilotriacetic Acid SCHEMBL9771757 0.93 TDP1 (0.73) TDP1EYA2APPACETSHR
Nitrilotriacetic Acid SCHEMBL8463064 0.93 TDP1 (0.73) TDP1EYA2APPACETSHR
Water SCHEMBL28807136 0.90 TDP1 (0.61) TDP1EYA2APPACETSHR
SCHEMBL3902066 0.90 TDP1 (0.61) TDP1EYA2APPACETSHR
Ammonia Solution, Strong SCHEMBL3913168 0.90 TDP1 (0.61) TDP1EYA2APPACETSHR
Phosphine SCHEMBL28313181 0.90 TDP1 (0.61) TDP1EYA2APPACETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 327 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12570585-B2 Methods and compositions for use in agricultural processes SOLUGEN, INC. (US) 2026-03-10 US claimed
US-20250136488-A1 Extended- and Multimodal-Release Compositions Finoric LLC 2025-05-01 US claimed
US-20230271892-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES SOLUGEN, INC. (US) 2023-08-31 US claimed
EP-3189116-B1 SLICK-WATER FRACTURING USING TIME RELEASE METAL-COMPLEXING AGENT FLEX CHEM HOLDING COMPANY LLC (US) 2023-08-09 EP claimed
EP-4188074-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES Solugen, Inc. (US) 2023-06-07 EP claimed
WO-2022115283-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL PH FLOOD HALLIBURTON ENERGY SERVICES, INC. (US) 2022-06-02 WO claimed
US-20220162498-A1 METHOD FOR IMPROVED OIL RECOVERY IN SUBTERRANEAN FORMATIONS WITH CIRCUMNEUTRAL pH FLOOD HALLIBURTON ENERGY SERVICES, INC. 2022-05-26 US claimed
US-11332658-B2 Stimulation of wells in nano-darcy shale formations FLEX-CHEM HOLDING COMPANY, LLC (US) 2022-05-17 US claimed
WO-2022026752-A1 METHODS AND COMPOSITIONS FOR USE IN AGRICULTURAL PROCESSES SOLUGEN, INC. (US) 2022-02-03 WO claimed
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ISP INVESTMENTS LLC (US) 2022-01-18 US claimed
US-20120115759-A1 TREATMENT FLUIDS CONTAINING A BORON TRIFLUORIDE COMPLEX AND METHODS FOR USE THEREOF HALLIBURTON ENERGY SERVICES, INC. (US) 2012-05-10 US claimed
US-20120097392-A1 Treatment Fluids Containing Biodegradable Chelating Agents and Methods for Use Thereof HALLIBURTON ENERGY SERVICES, INC. (US) 2012-04-26 US claimed
US-20120077994-A1 METHOD OF OBTAINING SECONDARY PLANT CONSTITUENTS SARTORIUS STEDIM BIOTECH GMBH (DE) 2012-03-29 US claimed
CN-1062855-C Process for preparing alkali metal salts of hydroxymethyl-iminodiacetic acid HAMPSHIRE CHEM CORP (US) 2001-03-07 CN claimed
EP-0595598-B1 Conversion of hydroxymethyl iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP (US) 1997-06-18 EP claimed
US-5312972-A Conversion of hydroxymethyl-iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORP. (US) 1994-05-17 US claimed
EP-0595598-A1 Conversion of hydroxymethyl iminodiacetic acid to phosphonomethyl-iminodiacetic acid HAMPSHIRE CHEMICAL CORPORATION (US) 1994-05-04 EP claimed
EP-0304315-B1 BATH FOR ELECTROLYTIC DEPOSITION OF A GOLD-COPPER-ZINC ALLOY ENGELHARD LIMITED (GB) 1993-03-03 EP claimed
EP-0121492-B1 GALVANIC BATH FOR THE ELECTROPLATING OF A GOLD-COPPER-CADMIUM ALLOY, PROCESS FOR USING IT AND ARTICLE RESULTING FROM THE PROCESS Emmenegger, Heinz (CH) 1988-06-15 EP claimed
US-4486275-A HYDROXYALKYLAMINODIACETATE COMPLEXING AGENT EMMENEGGER HEINZ (CH) 1984-12-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12570585-B2 Methods and compositions for use in agricultural processes SLC5A6, SLC5A2, HK2 TDP1 4101/4885EYA2 1002/4885APP 4376/4885
US-11224222-B2 Synergistic compositions of dehydroacetic acid and methods for reducing yellowing in various end-user compositions ALAD, SCD, DHCR7 TDP1 1238/4885EYA2 200/4885APP 453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.